• Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming

James M. Golubieski, President of New Jersey Health Foundation/Foundation Venture Capital Group,

Impact Investing

James M. Golubieski

James M. Golubieski

James M. Golubieski is president of Foundation Venture Capital Group and New Jersey Health Foundation.

Mr. Golubieski had been chief financial officer of Array Medical, Inc., a medical device company established in 1995 that developed a groundbreaking blood test to assess platelet function. The company was sold in 1999.

For 10 years prior, he had been with KPMG, one of the largest professional services companies in the world.

Mr. Golubieski is a member of the New Jersey Economic Development Authority’s Technology Advisory Board, which evaluates and recommends start-up companies for investment and the New Jersey Department of Labor and Workforce Development’s BIO-1 Project, a plan to retain and expand high-quality jobs in central New Jersey’s bioscience sector.

Recent Articles By James M. Golubieski

Do you want to incorporate an impact investment strategy into your overall organization mission without adversely influencing your investment returns?   That was the dilemma faced by New Jersey Health Foundation as we began to explore ways to expand our mission without...